Roche announces Xelox study results
Monday, October 2nd, 2006Roche announced today (Monday, Oct 2, 2006) that their Phase III study showed chemotherapy and Xelox to be as effective as the current standard treatment of advanced colorectal cancer.
Details from the data are expected to be presented for the first time at the 31st European Society for Medical Oncology Congress.